Developing an efficient delivery system for enhanced and controlled gene interference-based therapeutics is an existing challenge in molecular biology. The advancing field of nanotechnology can provide an effective, cross-disciplinary ...
The CRISPR-Cas system has become the go-to tool for researchers who study genes in an ever-growing list of organisms, and is being used to develop new gene therapies that potentially can correct a defect at a single nucleotide ...
Two radioactive isotopes of the metallic element scandium, or Sc, appear to be ideal for visualizing, and then destroying, solid tumors. A barrier, however, blocks their use—the inability to rapidly produce and purify the ...
Chemists funded by the SNSF have created a new compound for flexible drug delivery that specifically targets prostate cancer cells. Incorporating four different molecules, the compound prevents tumor cells from multiplying, ...
Russian scientists from Lebedev Physical Institute of the Russian Academy of Sciences, National Research Nuclear University MEPhI, G.G. Devyatykh Institute of Chemistry of High-Purity Substances of the Russian Academy, together ...
Theranostics is an emerging field of medicine whose name is a combination of "therapeutics" and "diagnostics." The idea behind theranostics is to combine drugs and/or techniques to simultaneously—or sequentially—diagnose ...
Emerging single-cell diagnostics rely on the potential to rapidly and efficiently isolate bacteria from complex biological matrices. In a recent study now published in Microsystems and Nanoengineering, Jung Y. Han and colleagues ...
Hepatocyte Growth Factor (HGF) is a protein that acts as a cell growth factor. By binding to its receptor protein MET on the cell membrane, it exerts its physiological functions such as proliferation and migration of cells, ...
Researchers at Kanazawa University report in ACS Omega a promising combination of radioisotope-carrying molecules for use in radiotheranostics—a diagnosis and treatment approach based on the combination of medical imaging ...
Cancer kills more than half a million men, women, and children each year in the U.S, and chemotherapy is only slightly more discriminating than the disease it treats. As a result, many cancer treatments kill cells throughout ...
